Is Pfizer’s (PFE) Dividend in Jeopardy Again?
The last time the company had a mega-takeover, its dividend took it on the chin (getting slashed in half to provide the required cash to see the deal through). Will this time be different?
Read MoreAuthor: Steve Mauzy, Wyatt Investment Research
Consider This Dividend Grower For Your Portfolio
The company has predictable growth, a unique business niche, solid fundamentals, annual dividend growth and portfolio diversification benefits…
Read More
This Stock Offers the Potential for a Rising Income Stream if the Fed Raises Interest Rates
And if the Fed doesn’t raise rates, investors still stand to get a stable source of high-yield income on the cheap…
Read MoreCaution: Don’t Be Fooled By This Stock’s 14% Dividend Yield
There’s nothing in the company’s history that suggests management can create and maintain long-term value for shareholders…
Read MoreThis Dividend Growth Stock Just Hit a New All-Time High
Those who continue to hold its shares continue to capture a rising stream of income and a rising share price…
Read More